Wang C, McGraw KL, McLemore AF, Komrokji R, et al. Dual pyroptotic biomarkers predict erythroid response in lower risk non-del(5q) myelodysplastic syndromes treated with lenalidomide and recombinant erythropoietin. Haematologica 2021 Jul 29. doi: 10.3324/haematol.2021.278855.
PMID: 34320786